11,333.00
+88(+0.78%)
Currency In ZAc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
8867
First IPO Date
January 04, 2000
Name | Title | Pay | Year Born |
Mr. Stephen Bradley Saad BCom, CA(SA) | Group Chief Executive Officer & Executive Director | 22.36M | 1964 |
Mr. Samer Kassem | Chief Executive Officer of Aspen Global Incorporated | 0 | 1975 |
Mr. Trevor Julian Ziman | Regional Chief Executive Officer of Asia Pacific | 0 | 1972 |
Mr. Michael Guy Attridge B.Com., CA(SA) | Group Chief Advisor | 7.79M | 1961 |
Ms. Zizipho Mmango | Group Chief Strategic Development Officer | 8.4M | 1985 |
Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA | Group Chief Corporate Officer & Executive Director | 9.32M | 1975 |
Mr. Sean M. Capazorio | Group Chief Financial Officer & Executive Director | 11.15M | 1967 |
Ms. Lorraine Hill | Group Chief Operations Officer | 11.77M | 1964 |
Ms. Sibongakonke Nkosi | Investor Relations Manager | 0 | N/A |
Ms. Raeesa Khan | Group Company Secretary & Chief of Staff | 0 | N/A |
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.